Shell Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Shell Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,558	Closed	-$860K	–	1282
2019 Q2	$860K	Sell	18,558 -423	-2%	-$11.9K	0.02%	630
2019 Q1	$463K	Hold	18,981	–	–	0.01%	942
2018 Q4	$270K	Sell	18,981 -1,600	-8%	-$24.3K	0.01%	1000
2018 Q3	$313K	Hold	20,581	–	–	0.01%	1058
2018 Q2	$345K	Sell	20,581 -1,200	-6%	-$19.1K	0.01%	1005
2018 Q1	$355K	Hold	21,781	–	–	0.01%	982
2017 Q4	$279K	Buy	+21,781	New	+$248K	0.01%	1020

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Shell Asset Management's ARRY Position: Q3 2019 in Review

Shell Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 18,558 shares — an estimated $860K sold.

Shell Asset Management first reported a position in ARRY in Q4 2017 and held it in 7 quarters. The position peaked at $860K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Shell Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Shell Asset Management sold 18,558 Array Biopharma Inc shares in Q3 2019, an estimated $860K.
Shell Asset Management first reported a position in Array Biopharma Inc in Q4 2017 and held it in 7 quarters.
Shell Asset Management's Array Biopharma Inc position peaked at $860K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Shell Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.